U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 52

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr11:128782003
GRCh38:
Chr11:128912108
KCNJ5E279KLong QT syndrome 13, Familial hyperaldosteronism type III, not provided
Uncertain significance
(Oct 14, 2021)
criteria provided, multiple submitters, no conflicts
2.
GRCh37:
Chr11:128782074
GRCh38:
Chr11:128912179
KCNJ5Cardiovascular phenotype, Long QT syndrome, Long QT syndrome 13,
Familial hyperaldosteronism type III
Likely benign
(Oct 7, 2021)
criteria provided, multiple submitters, no conflicts
3.
GRCh37:
Chr11:128786293-128786294
GRCh38:
Chr11:128916398-128916399
KCNJ5Long QT syndrome, Familial hyperaldosteronism type III, Long QT syndrome 13
Likely benign
(Aug 21, 2022)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr11:128781317
GRCh38:
Chr11:128911422
KCNJ5R50HCardiovascular phenotype, Long QT syndrome 13, Familial hyperaldosteronism type III,
Familial hyperaldosteronism type III, Long QT syndrome
Uncertain significance
(Oct 10, 2022)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr11:128781392
GRCh38:
Chr11:128911497
KCNJ5S75NCardiovascular phenotype, Long QT syndrome 13, Familial hyperaldosteronism type III,
Long QT syndrome
Uncertain significance
(Mar 14, 2022)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr11:128781427
GRCh38:
Chr11:128911532
KCNJ5R87CLong QT syndrome, not provided, Long QT syndrome 13,
Familial hyperaldosteronism type III, Cardiovascular phenotype
Uncertain significance
(Jun 8, 2022)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr11:128786321
GRCh38:
Chr11:128916426
KCNJ5R319Wnot provided, Long QT syndrome 13, Familial hyperaldosteronism type III
Uncertain significance
(May 9, 2022)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr11:128781786
GRCh38:
Chr11:128911891
KCNJ5Cardiovascular phenotype, Long QT syndrome 13, Familial hyperaldosteronism type III,
Long QT syndrome
Likely benign
(Dec 25, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr11:128781978
GRCh38:
Chr11:128912083
KCNJ5Familial hyperaldosteronism type III, Long QT syndrome 13, Long QT syndrome
Likely benign
(Mar 3, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr11:128781519
GRCh38:
Chr11:128911624
KCNJ5Long QT syndrome, Familial hyperaldosteronism type III, Long QT syndrome 13,
Cardiovascular phenotype
Likely benign
(Oct 7, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr11:128781799
GRCh38:
Chr11:128911904
KCNJ5R211WLong QT syndrome, Cardiovascular phenotype, Long QT syndrome 13,
Familial hyperaldosteronism type III
Uncertain significance
(Feb 23, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr11:128786360
GRCh38:
Chr11:128916465
KCNJ5R332*Long QT syndrome 13, Familial hyperaldosteronism type III, Long QT syndrome
Uncertain significance
(May 6, 2022)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr11:128786614
GRCh38:
Chr11:128916719
KCNJ5R416SCardiovascular phenotype, Familial hyperaldosteronism type III, Long QT syndrome 13
Uncertain significance
(Aug 24, 2021)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr11:128781700
GRCh38:
Chr11:128911805
KCNJ5V178IFamilial hyperaldosteronism type III, Long QT syndrome 13, Long QT syndrome
Uncertain significance
(Nov 12, 2021)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr11:128781442
GRCh38:
Chr11:128911547
KCNJ5V92ICardiovascular phenotype, Familial hyperaldosteronism type III, Long QT syndrome 13,
Long QT syndrome
Uncertain significance
(Jan 27, 2023)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr11:128781316
GRCh38:
Chr11:128911421
KCNJ5R50Cnot provided, Long QT syndrome, Long QT syndrome 13,
Familial hyperaldosteronism type III, Cardiovascular phenotype
Uncertain significance
(Jan 7, 2022)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr11:128781287
GRCh38:
Chr11:128911392
KCNJ5T40MLong QT syndrome, Familial hyperaldosteronism type III, Long QT syndrome 13
Uncertain significance
(Aug 24, 2021)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr11:128781382
GRCh38:
Chr11:128911487
KCNJ5R72WFamilial hyperaldosteronism type III, Long QT syndrome 13, Long QT syndrome,
not provided, Cardiovascular phenotype
Conflicting interpretations of pathogenicity
(Sep 14, 2022)
criteria provided, conflicting interpretations
19.
GRCh37:
Chr11:128761336
GRCh38:
Chr11:128891441
KCNJ5Long QT syndrome 13, Familial hyperaldosteronism type III, Familial hyperaldosteronism type III
Uncertain significance
(Sep 24, 2021)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr11:128786517
GRCh38:
Chr11:128916622
KCNJ5P384RCardiovascular phenotype, Long QT syndrome 13, Long QT syndrome
Uncertain significance
(Aug 23, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr11:128786586
GRCh38:
Chr11:128916691
KCNJ5K407RLong QT syndrome 13, Familial hyperaldosteronism type III, Long QT syndrome
Uncertain significance
(Sep 23, 2021)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr11:128781893
GRCh38:
Chr11:128911998
KCNJ5R242QLong QT syndrome, Long QT syndrome 13, Familial hyperaldosteronism type III
Uncertain significance
(Jul 5, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr11:128781606
GRCh38:
Chr11:128911711
KCNJ5Cardiovascular phenotype, Long QT syndrome, Familial hyperaldosteronism type III,
Long QT syndrome 13
Likely benign
(Oct 11, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr11:128781480
GRCh38:
Chr11:128911585
KCNJ5Cardiovascular phenotype, Familial hyperaldosteronism type III, Long QT syndrome 13,
not provided, Long QT syndrome
Benign/Likely benign
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr11:128781842
GRCh38:
Chr11:128911947
KCNJ5R225HLong QT syndrome, Cardiovascular phenotype, Familial hyperaldosteronism type III,
Long QT syndrome 13
Uncertain significance
(Apr 11, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr11:128782032
GRCh38:
Chr11:128912137
KCNJ5E288DHypertrophic cardiomyopathy, Long QT syndrome 13Conflicting interpretations of pathogenicity
(Feb 5, 2019)
criteria provided, conflicting interpretations
27.
GRCh37:
Chr11:128781813
GRCh38:
Chr11:128911918
KCNJ5Familial hyperaldosteronism type III, Long QT syndrome 13, Cardiovascular phenotype,
Long QT syndrome
Likely benign
(Oct 7, 2022)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr11:128786552
GRCh38:
Chr11:128916657
KCNJ5A396TCardiovascular phenotype, Long QT syndrome, Familial hyperaldosteronism type III,
Long QT syndrome 13
Uncertain significance
(Feb 7, 2022)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr11:128781576
GRCh38:
Chr11:128911681
KCNJ5Familial hyperaldosteronism type III, Long QT syndrome 13, Long QT syndrome,
Cardiovascular phenotype
Likely benign
(Apr 22, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr11:128781906
GRCh38:
Chr11:128912011
KCNJ5not provided, Cardiovascular phenotype, Long QT syndrome 13,
Familial hyperaldosteronism type III, Long QT syndrome
Benign/Likely benign
(Sep 9, 2022)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr11:128786515
GRCh38:
Chr11:128916620
KCNJ5Cardiovascular phenotype, Long QT syndrome 13, Familial hyperaldosteronism type III,
not provided, Long QT syndrome
Benign/Likely benign
(Aug 3, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr11:128781963
GRCh38:
Chr11:128912068
KCNJ5not specified, Long QT syndrome, Familial hyperaldosteronism type III,
Long QT syndrome 13
Likely benign
(Oct 5, 2021)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr11:128781535
GRCh38:
Chr11:128911640
KCNJ5D123NLong QT syndrome 13, Familial hyperaldosteronism type III, Long QT syndrome
Uncertain significance
(Apr 27, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr11:128781607
GRCh38:
Chr11:128911712
KCNJ5E147Knot provided, Long QT syndrome, Cardiovascular phenotype,
Familial hyperaldosteronism type III, Long QT syndrome 13, not specified
Uncertain significance
(Aug 10, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr11:128781833
GRCh38:
Chr11:128911938
KCNJ5G222DFamilial hyperaldosteronism type III, Long QT syndrome 13, not provided,
Long QT syndrome
Uncertain significance
(Jan 11, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr11:128786550
GRCh38:
Chr11:128916655
KCNJ5D395AFamilial hyperaldosteronism type III, Long QT syndrome 13, Long QT syndrome
Uncertain significance
(Aug 27, 2021)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr11:128787562
GRCh38:
Chr11:128917667
KCNJ5Familial hyperaldosteronism type III, Congenital long QT syndrome, Familial hyperaldosteronism type III,
Long QT syndrome 13
Uncertain significance
(Sep 17, 2021)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr11:128781912
GRCh38:
Chr11:128912017
KCNJ5Familial hyperaldosteronism type III, Long QT syndrome, Familial hyperaldosteronism type III,
Long QT syndrome 13, Cardiovascular phenotype, Congenital long QT syndrome,
not provided
Benign/Likely benign
(Oct 8, 2021)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr11:128781598
GRCh38:
Chr11:128911703
KCNJ5I144VFamilial hyperaldosteronism type III, Long QT syndrome, Long QT syndrome 13,
Cardiovascular phenotype, Congenital long QT syndrome, not provided
Conflicting interpretations of pathogenicity
(Jun 3, 2022)
criteria provided, conflicting interpretations
40.
GRCh37:
Chr11:128781441
GRCh38:
Chr11:128911546
KCNJ5Cardiovascular phenotype, Congenital long QT syndrome, Familial hyperaldosteronism type III,
Long QT syndrome 13, Long QT syndrome, Familial hyperaldosteronism,
not specified
Benign/Likely benign
(Jul 8, 2022)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr11:128761342
GRCh38:
Chr11:128891447
KCNJ5Familial hyperaldosteronism type III, Congenital long QT syndrome, Familial hyperaldosteronism type III,
Long QT syndrome 13
Uncertain significance
(Aug 16, 2021)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr11:128761336-128761337
GRCh38:
Chr11:128891441-128891442
KCNJ5Congenital long QT syndrome, Familial hyperaldosteronism type III, Long QT syndrome 13,
Familial hyperaldosteronism
Uncertain significance
(Jul 26, 2021)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr11:128761336-128761337
GRCh38:
Chr11:128891441-128891442
KCNJ5Congenital long QT syndrome, Familial hyperaldosteronism type III, Long QT syndrome 13,
Familial hyperaldosteronism
Uncertain significance
(Jul 13, 2021)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr11:128761334-128761338
GRCh38:
Chr11:128891439-128891443
KCNJ5Familial hyperaldosteronism, Congenital long QT syndrome, Familial hyperaldosteronism type III,
Long QT syndrome 13
Uncertain significance
(Aug 19, 2021)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr11:128786490
GRCh38:
Chr11:128916595
KCNJ5R375QLong QT syndrome, Long QT syndrome 13, Familial hyperaldosteronism type III,
Cardiovascular phenotype
Uncertain significance
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr11:128781993
GRCh38:
Chr11:128912098
KCNJ5Long QT syndrome, not provided, Cardiovascular phenotype,
Long QT syndrome 13, Familial hyperaldosteronism type III
Likely benign
(Oct 7, 2022)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr11:128786294
GRCh38:
Chr11:128916399
KCNJ5Congenital long QT syndrome, not specified, Long QT syndrome,
Familial hyperaldosteronism type III, Long QT syndrome 13
Benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr11:128782012
GRCh38:
Chr11:128912117
KCNJ5Q282ECardiovascular phenotype, Congenital long QT syndrome, not specified,
Long QT syndrome, Familial hyperaldosteronism type III, Long QT syndrome 13
Benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr11:128782002
GRCh38:
Chr11:128912107
KCNJ5Cardiovascular phenotype, Congenital long QT syndrome, not specified,
Long QT syndrome, Familial hyperaldosteronism type III, Long QT syndrome 13
Benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr11:128781978
GRCh38:
Chr11:128912083
KCNJ5Cardiovascular phenotype, Familial hyperaldosteronism type III, Long QT syndrome 13,
Congenital long QT syndrome, not specified, Long QT syndrome,
Familial hyperaldosteronism type III, Long QT syndrome 13
Benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr11:128781339
GRCh38:
Chr11:128911444
KCNJ5Cardiovascular phenotype, Congenital long QT syndrome, not specified,
Long QT syndrome, Familial hyperaldosteronism type III, Long QT syndrome 13
Benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr11:128786525
GRCh38:
Chr11:128916630
KCNJ5G387RCardiovascular phenotype, Familial hyperaldosteronism type III, Long QT syndrome,
Long QT syndrome 13
Conflicting interpretations of pathogenicity
(Nov 28, 2022)
criteria provided, conflicting interpretations
Format
Items per page
Sort by
Choose Destination